世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Heparin Active Pharmaceutical Ingredients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin Active Pharmaceutical Ingredients was estimated to be worth US$ 1837 million in 2024 and is forecast to a readjusted size of US$ 3083 million by 2031 with a CAGR of 7.... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Heparin Active Pharmaceutical Ingredients was estimated to be worth US$ 1837 million in 2024 and is forecast to a readjusted size of US$ 3083 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API. The Global key players of Heparin Active Pharmaceutical Ingredients include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, etc. The top three players hold a share over 39%. Asia-Pacific is the largest market, and has a share about 36%. In terms of product type, Heparin Sodium is the largest segment, which occupied for a share of about 97%. For application, LMWH is the largest segment, which has a share about 87%. This report aims to provide a comprehensive presentation of the global market for Heparin Active Pharmaceutical Ingredients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin Active Pharmaceutical Ingredients by region & country, by Type, and by Application. The Heparin Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Active Pharmaceutical Ingredients. Market Segmentation By Company Shenzhen Hepalink Pharmaceutical Yantai Dongcheng Pharmaceutical Pfizer Bioibérica Changzhou Qianhong Biopharma Nanjing King-friend Biochemical Pharmaceutical Hebei Changshan Biochemical Pharmaceutical Qingdao Jiulong Biopharmaceutical Opocrin Dongying Tiandong Pharmaceutical Aspen Oss Yino Pharma Nanjing Xinbai Pharmaceutical Hubei Enoray Biopharmaceutical Cisen Pharmaceutical Segment by Type Heparin Sodium Heparin Calcium Segment by Application UFH LMWH By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Heparin Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Heparin Active Pharmaceutical Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Heparin Active Pharmaceutical Ingredients in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Heparin Active Pharmaceutical Ingredients Product Introduction 1.2 Global Heparin Active Pharmaceutical Ingredients Market Size Forecast 1.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value (2020-2031) 1.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume (2020-2031) 1.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Price (2020-2031) 1.3 Heparin Active Pharmaceutical Ingredients Market Trends & Drivers 1.3.1 Heparin Active Pharmaceutical Ingredients Industry Trends 1.3.2 Heparin Active Pharmaceutical Ingredients Market Drivers & Opportunity 1.3.3 Heparin Active Pharmaceutical Ingredients Market Challenges 1.3.4 Heparin Active Pharmaceutical Ingredients Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Heparin Active Pharmaceutical Ingredients Players Revenue Ranking (2024) 2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Company (2020-2025) 2.3 Global Heparin Active Pharmaceutical Ingredients Players Sales Volume Ranking (2024) 2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Company Players (2020-2025) 2.5 Global Heparin Active Pharmaceutical Ingredients Average Price by Company (2020-2025) 2.6 Key Manufacturers Heparin Active Pharmaceutical Ingredients Manufacturing Base and Headquarters 2.7 Key Manufacturers Heparin Active Pharmaceutical Ingredients Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Heparin Active Pharmaceutical Ingredients 2.9 Heparin Active Pharmaceutical Ingredients Market Competitive Analysis 2.9.1 Heparin Active Pharmaceutical Ingredients Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Active Pharmaceutical Ingredients Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Active Pharmaceutical Ingredients as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Heparin Sodium 3.1.2 Heparin Calcium 3.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type 3.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (2020-2031) 3.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (%) (2020-2031) 3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type 3.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (2020-2031) 3.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (%) (2020-2031) 3.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 UFH 4.1.2 LMWH 4.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application 4.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (2020-2031) 4.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (%) (2020-2031) 4.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application 4.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (2020-2031) 4.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (%) (2020-2031) 4.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region 5.1.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2020-2025) 5.1.3 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2026-2031) 5.1.4 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), (2020-2031) 5.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region 5.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2020-2025) 5.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2026-2031) 5.2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (%), (2020-2031) 5.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 5.4.2 North America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 5.5.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 5.6.2 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 5.7.2 South America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 5.8.2 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value 6.2.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.2.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.3.2 United States Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.4.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.5.2 China Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2024 VS 2031 6.5.3 China Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.6.2 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.7.2 South Korea Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.8.2 Southeast Asia Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Heparin Active Pharmaceutical Ingredients Sales Value, 2020-2031 6.9.2 India Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2024 VS 2031 6.9.3 India Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Shenzhen Hepalink Pharmaceutical 7.1.1 Shenzhen Hepalink Pharmaceutical Company Information 7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview 7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development 7.2 Yantai Dongcheng Pharmaceutical 7.2.1 Yantai Dongcheng Pharmaceutical Company Information 7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview 7.2.3 Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.2.5 Yantai Dongcheng Pharmaceutical Recent Development 7.3 Pfizer 7.3.1 Pfizer Company Information 7.3.2 Pfizer Introduction and Business Overview 7.3.3 Pfizer Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Pfizer Heparin Active Pharmaceutical Ingredients Product Offerings 7.3.5 Pfizer Recent Development 7.4 Bioibérica 7.4.1 Bioibérica Company Information 7.4.2 Bioibérica Introduction and Business Overview 7.4.3 Bioibérica Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Bioibérica Heparin Active Pharmaceutical Ingredients Product Offerings 7.4.5 Bioibérica Recent Development 7.5 Changzhou Qianhong Biopharma 7.5.1 Changzhou Qianhong Biopharma Company Information 7.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview 7.5.3 Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Product Offerings 7.5.5 Changzhou Qianhong Biopharma Recent Development 7.6 Nanjing King-friend Biochemical Pharmaceutical 7.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information 7.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview 7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development 7.7 Hebei Changshan Biochemical Pharmaceutical 7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information 7.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview 7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Development 7.8 Qingdao Jiulong Biopharmaceutical 7.8.1 Qingdao Jiulong Biopharmaceutical Company Information 7.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview 7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.8.5 Qingdao Jiulong Biopharmaceutical Recent Development 7.9 Opocrin 7.9.1 Opocrin Company Information 7.9.2 Opocrin Introduction and Business Overview 7.9.3 Opocrin Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Opocrin Heparin Active Pharmaceutical Ingredients Product Offerings 7.9.5 Opocrin Recent Development 7.10 Dongying Tiandong Pharmaceutical 7.10.1 Dongying Tiandong Pharmaceutical Company Information 7.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview 7.10.3 Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.10.5 Dongying Tiandong Pharmaceutical Recent Development 7.11 Aspen Oss 7.11.1 Aspen Oss Company Information 7.11.2 Aspen Oss Introduction and Business Overview 7.11.3 Aspen Oss Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Aspen Oss Heparin Active Pharmaceutical Ingredients Product Offerings 7.11.5 Aspen Oss Recent Development 7.12 Yino Pharma 7.12.1 Yino Pharma Company Information 7.12.2 Yino Pharma Introduction and Business Overview 7.12.3 Yino Pharma Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 Yino Pharma Heparin Active Pharmaceutical Ingredients Product Offerings 7.12.5 Yino Pharma Recent Development 7.13 Nanjing Xinbai Pharmaceutical 7.13.1 Nanjing Xinbai Pharmaceutical Company Information 7.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview 7.13.3 Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.13.5 Nanjing Xinbai Pharmaceutical Recent Development 7.14 Hubei Enoray Biopharmaceutical 7.14.1 Hubei Enoray Biopharmaceutical Company Information 7.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview 7.14.3 Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.14.5 Hubei Enoray Biopharmaceutical Recent Development 7.15 Cisen Pharmaceutical 7.15.1 Cisen Pharmaceutical Company Information 7.15.2 Cisen Pharmaceutical Introduction and Business Overview 7.15.3 Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Offerings 7.15.5 Cisen Pharmaceutical Recent Development 8 Industry Chain Analysis 8.1 Heparin Active Pharmaceutical Ingredients Industrial Chain 8.2 Heparin Active Pharmaceutical Ingredients Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Heparin Active Pharmaceutical Ingredients Sales Model 8.5.2 Sales Channel 8.5.3 Heparin Active Pharmaceutical Ingredients Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（active pharmaceutical）の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
